Grown Rogue International Inc. Share Price
Stocks
GRIN
CA39986R3045
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Canadian Securities Exchange
02:29:59 07/11/2026 am IST
|
5-day change | 1st Jan Change | ||
| 0.4700 CAD | -6.00% |
|
+2.17% | -32.86% |
| 21/10 | Grown Rogue International Increases Ownership Interest in New Jersey Subsidiary to 70% | MT |
| 20/10 | Grown Rogue International Inc. acquired an additional 26% stake in ABCO Garden State, LLC. | CI |
| Market Cap | 8.33Cr 7.47Cr 6.83Cr 6.23Cr 12Cr 783.29Cr 12Cr 82Cr 33Cr 417.95Cr 31Cr 31Cr 1.32TCr | P/E 2024 |
-12x | P/E 2025 | 71.9x |
|---|---|---|---|---|---|
| Enterprise Value | 9.86Cr 8.85Cr 8.08Cr 7.38Cr 14Cr 927.11Cr 14Cr 97Cr 39Cr 494.69Cr 37Cr 36Cr 1.56TCr | EV / Sales 2024 |
5.45x | EV / Sales 2025 | 4.4x |
| Free-Float |
61.83% | Yield 2024 * |
-
| Yield 2025 | - |
Canadian Securities ExchangeCAD
| Markets | Quality | ||
|---|---|---|---|
Canadian Securities Exchange
| GRIN | Delayed | |
OTC Markets
| GRUSF | Delayed | |
|
Deutsche Boerse AG
| 1VF0 | Delayed |
Last Transcript: Grown Rogue International Inc.
| 1 day | -6.00% | ||
| 1 week | +2.17% | ||
| Current month | +2.17% | ||
| 1 month | -17.54% | ||
| 3 months | -21.67% | ||
| 6 months | -4.08% | ||
| Current year | -32.86% |
| 1 week | 0.47 |  | 0.57 |
| 1 month | 0.46 | | 0.59 |
| Current year | 0.38 | | 0.72 |
| 1 year | 0.38 | | 0.72 |
| 3 years | 0.32 | | 1.15 |
| 5 years | 0.06 | | 1.15 |
| 10 years | 0.06 | | 1.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sarah Strickler
PRN | Corporate Officer/Principal | - | 01/10/2016 |
J. Strickler
CEO | Chief Executive Officer | 45 | 15/11/2018 |
| Director of Finance/CFO | 42 | 01/01/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Gledhill
BRD | Director/Board Member | 64 | 15/11/2018 |
J. Strickler
CHM | Chairman | 45 | - |
Ryan Kee
BRD | Director/Board Member | 42 | 01/01/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 21/07/26 | Option | Director | 1,20,000 | 0.0480% | ||
| 21/07/26 | Option | Director | 1,20,000 | 0.0480% | ||
| 21/07/26 | Free | Founder | 10,00,000 | 0.4001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.00% | +2.17% | -4.08% | +20.51% | 8.33Cr | |
| -0.79% | -4.48% | +46.48% | +125.69% | 1,20600Cr | |
| +1.43% | +1.11% | +48.05% | +83.05% | 66TCr | |
| +1.07% | -1.21% | +32.92% | +104.92% | 51TCr | |
| -0.36% | -3.25% | +45.42% | +65.10% | 38TCr | |
| -0.14% | -1.87% | +70.06% | +41.09% | 36TCr | |
| -0.78% | -0.52% | +30.47% | +58.09% | 31TCr | |
| -0.80% | -0.21% | +7.98% | +36.17% | 29TCr | |
| +0.03% | -1.20% | +43.79% | +69.83% | 25TCr | |
| -0.41% | -2.22% | +40.43% | +107.03% | 21TCr | |
| Average | -0.68% | -1.17% | +36.15% | +71.15% | 41.8TCr | |
| Weighted average by Cap. | -0.04% | -1.96% | +42.71% | +88.11% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.7Cr 2.42Cr 2.21Cr 2.02Cr 3.81Cr 253.97Cr 3.93Cr 27Cr 11Cr 135.51Cr 10Cr 9.92Cr 427.8Cr | 3.24Cr 2.91Cr 2.66Cr 2.43Cr 4.57Cr 304.83Cr 4.72Cr 32Cr 13Cr 162.65Cr 12Cr 12Cr 513.47Cr |
| Net income | -1.13Cr -1.01Cr -92.65L -84.58L -1.59Cr -106.26Cr -1.64Cr -11Cr -4.45Cr -57Cr -4.24Cr -4.15Cr -178.99Cr | 17.3L 15.51L 14.18L 12.94L 24.39L 16Cr 25.15L 1.71Cr 68.15L 8.68Cr 64.93L 63.54L 27Cr |
| Net Debt | 37.04L 33.22L 30.36L 27.72L 52.22L 35Cr 53.87L 3.66Cr 1.46Cr 19Cr 1.39Cr 1.36Cr 59Cr | 1.53Cr 1.37Cr 1.25Cr 1.14Cr 2.16Cr 143.82Cr 2.22Cr 15Cr 6.03Cr 77Cr 5.74Cr 5.62Cr 242.26Cr |
Employees
-
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/26/06 | CA$0.4700 | -6.00% | 19,000 |
| 05/26/05 | CA$0.5000 | -1.96% | 47,603 |
| 04/26/04 | CA$0.5100 | 0.00% | 4,472 |
| 03/26/03 | CA$0.5100 | 0.00% | 13,000 |
| 02/26/02 | CA$0.5100 | +10.87% | 1,54,500 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- GRIN Stock
Select your edition
All financial news and data tailored to specific country editions
